The company found some relief after adding GLP-1 obesity treatment offerings in 2023, but still hasn’t strayed from the more traditional approach to weight loss, focusing on food intake and ...

long-term weight loss process. Novo Nordisk has had its NDA for an oral formulation of Wegovy accepted by the FDA. It would be the first obesity-targeted GLP-1 in pill form. The importance of ...

A young mum has candidly opened up about her weight loss journey that took a concerning ... At 15st (95kg), Miranda delved into research on GLP-1 medications, an emerging category of injectable ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...

A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%.

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But ...

Shares of WW International Inc. plunged Wednesday after the health and wellness company known as WeightWatchers filed for bankruptcy, facing a mounting debt burden that offering weight-loss drugs ...